The Prevention of Contrast Induced Nephropathy by Sarpogrelate: a Prospective Randomized Controlled Clinical Trial.

CONCLUSION: This study failed to demonstrate that sarpogrelate has a renoprotective effect against contrast induced acute kidney injury.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01165567.
PMID: 31625293 [PubMed - in process]

Source: J Korean Med Sci - October 19, 2019 Category: General Medicine Authors: Ki YJ, Kwon SA, Kim HL, Seo JB, Chung WY Tags: J Korean Med Sci Source Type: research